This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Companies in this article
Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the acquisition of a currently approved Abbreviated New Drug Application (ANDA) for naltrexone hydrochloride 50 mg tablets from Mikah Pharma LLC ("Mikah").
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.